ROBERTS EIRY bought NBIX
February 12, 2025 · Form 4 insider transaction
ROBERTS EIRY bought 43,261 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
43,261
Price
$0.00
Total value
N/A
InsiderROBERTS EIRY
RoleDirector
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2025
Filing dateFebruary 14, 2025
Shares owned after43,261
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 12, 2025 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.